Background: This study assesses COVID-19 hospitalised patient demography and outcomes during wave 1 and wave 2, prior to new variants of the virus.

Methods: All patients with a positive SARS-CoV-2 swab between 10th March 2020 and 5th July 2020 (wave 1) and 1st September 2020 and 16th November 2020 (wave 2) admitted to University Hospitals Birmingham NHS Foundation Trust were included (n=4856), followed for 28 days.

Results: Wave 2 patients were younger, more ethnically diverse, had less co-morbidities and disease presentation was milder on presentation. After matching for these factors, mortality was reduced, but without differences in intensive care admissions.

Conclusion: Prior to new SARS-CoV-2 variants, outcomes for hospitalised patients with COVID-19 were improving but with similar intensive care needs.

References

1. Gebru AA, Birhanu T, Wendimu E, Ayalew AF, Mulat S, Abasimel HZ, Kazemi A, Tadesse BA, Gebru BA, Deriba BS, Zeleke NS, Girma AG, Munkhbat B, Yusuf QK. Global burden of COVID-19: Situational analyis and review. Human Antibodies 2020; Preprint: 1-10.
2. Public Health England. The Health Protection (Coronavirus, Restrictions) (England) Regulations 2020. https:// wwwlegislationgovuk/uksi/2020/350/introduction 2020; DOA 28th Dec 2020.
3. Gov.uk. Coronavirus (COVID-19) Guidance and support. Find out the coronavirus restrictions in your local area. https://wwwgovuk/find-coronavirus-local-restrictions 2020; DOA 27th Dec 2020.
4. Gov.uk. The Health Protection (Coronavirus, Restrictions) (No. 2) (England) Regulations 2020 S! 2020/684). https:// wwwlegislationgovuk/uksi/2020/684/contents 2020; DOA 27th Dec 2020.
5. Gov.uk. Face coverings to be mandatory in shops and supermarkets from 24 July. https://wwwgovuk/government/speeches/facecoverings-to-be-mandatory-in-shops-and-supermarkets-from24-july 2020; DOA 27th Dec 2020.
6. UK Parliament. Research Briefing. Coronavirus: A history of English lockdown laws. https://commonslibraryparliamentuk/ research-briefings/cbp-9068/ 2021; Date of access 21st Januay 2021.
7. Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report. New England Journal of Medicine 2020.
8. Spinner CD, Gottlieb RL, Criner GJ, Arribas López JR, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang S-C, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wang H, Gaggar A, Brainard DM, McPhail MJ, Bhagani S, Ahn MY, Sanyal AJ, Huhn G, Marty FM, for the GSUSI. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA 2020; 324: 1048-1057.
9. National Institute for Health C-TGP. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://wwwcovid19treatmentguidelinesnihgov/ 2020; DOA 21st January 2021.
10. Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy J-PR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical Microbiology and Infection 2020; 26: 1622-1629.
11. Koyama T, Platt D, Parida L. Variant analysis of SARS-CoV-2 genomes. Bull World Health Organ 2020; 98: 495-504.
12. Wise J. Covid-19: New coronavirus variant is identified in UK. BMJ 2020; 371: m4857.
13. New and Emerging Respiratory Virus Threats Advisory Group. NERVTAG meeting on SARS-CoV-2 variant under investigation VUI-202012/01. https://khubnet/ documents/135939561/338928724/SARS-CoV-2+variant+un der+investigation%2C+meeting+minutespdf/962e866b-161f2fd5-1030-32b6ab467896?t=1608491166921 2020; DOA 27th December 2020.
14. Hall M, Pritchard M, Dankwa EA, Baillie JK, Carson G, Citarella BW, Docherty A, Donnelly CA, Dunning J, Fraser C, Hardwick H, Harrison EM, Holden KA, Kartsonaki C, Kennon K, Lee J, McLean K, Openshaw PJM, Plotkin D, Rojek A, Russell CD, Semple MG, Sigfrid L, Smith S, Horby P, Olliaro P, Merson L. ISARIC Clinical Data Report 20 November 2020. medRxiv 2020: 2020.2007.2017.20155218.
15. Carver K, Jones N. Compartive accuracy of oropharyngeal and nasopharyngeal swabs for diagnosis of COVID-19. Oxford COVID-19 Evidence Service Team Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences University of Oxford 2020; https://www.cebm.net/covid-19/ comparative-accuracy-of-oropharyngeal-and-nasopharyngealswabs-for-diagnosis-of-covid-19/.
16. NHS England. Guidance and standard operating procedure COVID-19 virus testing in NHS laboratories. NHS England and Improvements 2020; https://www.england.nhs.uk/coronavirus/ wp-content/uploads/sites/52/2020/03/guidance-and-sop-covid19-virus-testing-in-nhs-laboratories-v1.pdf.
17. Public Health England. New SARS-CoV-2 variant Information on the new variant of the SARS-CoV-2 virus. https://wwwgovuk/ government/collections/new-sars-cov-2-variant 2020; DOA 27th Dec 2020.
18. NHS Digital. The NHS Digital SNOMED CT Browser. https:// termbrowsernhsuk/? 2020; DOA 10.4.2020.
19. Organisation. WH. ICD-10 online versions. https://wwwwhoint/ classifications/icd/icdonlineversions/en/ 2019; DOA 3.3.2020.
20. Guan W-j, Liang W-h, Zhao Y, Liang H-r, Chen Z-s, Li Y-m, Liu X-q, Chen R-c, Tang C-l, Wang T, Ou C-q, Li L, Chen P-y, Sang L, Wang W, Li J-f, Li C-c, Ou L-m, Cheng B, Xiong S, Ni Z-y, Xiang J, Hu Y, Liu L, Shan H, Lei C-l, Peng Y-x, Wei L, Liu Y, Hu Y-h, Peng P, Wang J-m, Liu J-y, Chen Z, Li G, Zheng Z-j, Qiu S-q, Luo J, Ye C-j, Zhu S-y, Cheng L-l, Ye F, Li S-y, Zheng J-p, Zhang N-f, Zhong N-s, He J-x. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. European Respiratory Journal 2020: 2000547.
21. Ministry of Housing Calg. The English Indices of Deprivation 2019 Technical report. https://deraioeacuk/34259/1/IoD2019_ Technical_Reportpdf 2019; DOA 10.4.2020.
22. Office for National Statistics. Ethnic group, national identity and religion. Measuing equality: a guide for the collection and classification of ethnic group, national identity and religion data in the UK. https://wwwonsgovuk/ methodology/classificationsandstandards/measuringequality/ ethnicgroupnationalidentityandreligion 2016; DOA 20th March 2020.
23. Sapey E, Gallier S, Mainey C, Nightingale P, McNulty D, Corothers H, Evison F, Reeves K, Pagano D, Denniston AK, Nirantharakumar K, Diggle P, Ball S. Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area. BMJ OPen Respiratory Research 2020; doi: bmjresp-2020-000644: 1 - 11.
24. Gov.uk. The official UK Government website for data and insights on Coronavirus (COVID-19). https://coronavirusdatagovuk 2020; DOA 27th December 2020.
25. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh M-d, Ruiz-Palacios GM, Benfield T, Fätkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC. Remdesivir for the Treatment of Covid-19 — Final Report. New England Journal of Medicine 2020; 383: 1813-1826.
26. Harrison SL, Fazio-Eynullayeva E, Lane DA, Underhill P, Lip GYH. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis. PLOS Medicine 2020; 17: e1003321.
27. Malik P., Patel U., Patel K., Martin M, Shah C, Malik FA, Sharma A. Obesity a predictor of outcomes of COVID-19 hospitalized patients-A systematic review and meta-analysis. Journal of Medical Virology 2020; DOI: 10.1002/jmv.26555
28. Birmingham City Council. Birmingham Health Profile 2019. wwwbirminghamgovuk 2019; DOA 27th December 2020.
29. Hawkins RB, Charles EJ, Mehaffey JH. Socio-economic status and COVID-19–related cases and fatalities. Public Health 2020; 189: 129-134.
30. Carter B, Collins JT, Barlow-Pay F, Rickard F, Bruce E, Verduri A, Quinn TJ, Mitchell E, Price A, Vilches-Moraga A, Stechman MJ, Short R, Einarsson A, Braude P, Moug S, Myint PK, Hewitt J, Pearce L, McCarthy K, Davey C, Jones S, Lunstone K, Cavenagh A, Silver C, Telford T, Simmons R, Holloway M, Hesford J, El Jichi Mutasem T, Singh S, Paxton D, Harris W, Galbraith N, Bhatti E, Edwards J, Duffy S, Kelly J, Murphy C, Bisset C, Alexander R, Garcia M, Sangani S, Kneen T, Lee T, McGovern A, Guaraldi G, Clini E. Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople). Journal of Hospital Infection 2020; 106: 376-384.
31. Tillett RL, Sevinsky JR, Hartley PD, Kerwin H, Crawford N, Gorzalski A, Laverdure C, Verma SC, Rossetto CC, Jackson D, Farrell MJ, Van Hooser S, Pandori M. Genomic evidence for reinfection with SARS-CoV-2: a case study. The Lancet Infectious Diseases 2021; 21: 52-58.